MADISON, Wis.--(BUSINESS WIRE)--New research by Usona Institute identifies the most favorable environments to achieve consistency and reproducibility of pharmaceutical psilocybin produced at large ...

(a) Microscopic image and schematic representation of crystal polymorphs obtained via heteroepitaxial growth (α-phase: green; β-phase: red). Polystyrene particles with a diameter of 860 nm were used ...

Crystal polymorphism is critically important in the fields of pharmaceuticals and materials science. For instance, a metastable polymorph of an active pharmaceutical ingredient may benefit from ...

Pharmaceutical compounds often crystallize in a variety of forms known as polymorphs. Because of differences in stability, solubility, and other properties that affect the molecules’ behavior in the ...

This image by Shaista Hassan Lone, a scientist at the University of Kashmir, shows two polymorphs—different crystal structures—of 4-(dimethylamino)benzaldehyde. When Lone initially set out to grow ...

Polymorphism is observed in most active pharmaceutical ingredients (APIs), due to the different forms or molecular structures of a compound affecting the efficacy, stability or bio-availability of the ...